Phuong N. Huynh

Array ( [id] => 6174264 [patent_doc_number] => 20110177071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 13/045335 [patent_app_country] => US [patent_app_date] => 2011-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 132052 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177071.pdf [firstpage_image] =>[orig_patent_app_number] => 13045335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8374920 [patent_doc_number] => 08257711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides' [patent_app_type] => utility [patent_app_number] => 13/040177 [patent_app_country] => US [patent_app_date] => 2011-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10230 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13040177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898322 [patent_doc_number] => 08921537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Anti-VEGF antibodies' [patent_app_type] => utility [patent_app_number] => 13/039881 [patent_app_country] => US [patent_app_date] => 2011-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 45815 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13039881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8151937 [patent_doc_number] => 08168410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Anti-IGF-IR antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/037734 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 84 [patent_no_of_words] => 41830 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168410.pdf [firstpage_image] =>[orig_patent_app_number] => 13037734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159172 [patent_doc_number] => 20110158905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use' [patent_app_type] => utility [patent_app_number] => 13/036820 [patent_app_country] => US [patent_app_date] => 2011-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 79589 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20110158905.pdf [firstpage_image] =>[orig_patent_app_number] => 13036820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935858 [patent_doc_number] => 20110212051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'VARIANTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/037196 [patent_app_country] => US [patent_app_date] => 2011-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 299 [patent_figures_cnt] => 299 [patent_no_of_words] => 234789 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212051.pdf [firstpage_image] =>[orig_patent_app_number] => 13037196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8963044 [patent_doc_number] => 20130202646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING AUTOPHAGY' [patent_app_type] => utility [patent_app_number] => 13/580867 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27746 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13580867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964252 [patent_doc_number] => 09011861 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'Therapeutic compositions for the treatment of dry eye disease' [patent_app_type] => utility [patent_app_number] => 13/035695 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 17031 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13035695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8510535 [patent_doc_number] => 20120309943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'ANTIBODY-IMMOBILIZED CARRIER, METHOD OF PRODUCING ANTIBODY-IMMOBILIZED CARRIER, AND USE OF SAID ANTIBODY-IMMOBILIZED CARRIER' [patent_app_type] => utility [patent_app_number] => 13/578974 [patent_app_country] => US [patent_app_date] => 2011-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22890 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972476 [patent_doc_number] => 20110152174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'INHIBITION OF SECRETION FROM NON-NEURONAL CELLS' [patent_app_type] => utility [patent_app_number] => 13/022184 [patent_app_country] => US [patent_app_date] => 2011-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21352 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152174.pdf [firstpage_image] =>[orig_patent_app_number] => 13022184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8351633 [patent_doc_number] => 08246960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Methods and compositions for generating bioactive assemblies of increased complexity and uses' [patent_app_type] => utility [patent_app_number] => 13/021302 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19256 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13021302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9215953 [patent_doc_number] => 08628749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Radioimmunoconjugates and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/522678 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10009 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6183767 [patent_doc_number] => 20110123529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/016709 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 54303 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123529.pdf [firstpage_image] =>[orig_patent_app_number] => 13016709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435166 [patent_doc_number] => 08282934 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology' [patent_app_type] => utility [patent_app_number] => 13/012977 [patent_app_country] => US [patent_app_date] => 2011-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22950 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13012977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6109977 [patent_doc_number] => 20110189083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Dock-and-Lock (DNL) Vaccines for Cancer Therapy' [patent_app_type] => utility [patent_app_number] => 13/010993 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25780 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189083.pdf [firstpage_image] =>[orig_patent_app_number] => 13010993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102831 [patent_doc_number] => 20110166324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'IMMUNOSUPPRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 13/011497 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 132034 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166324.pdf [firstpage_image] =>[orig_patent_app_number] => 13011497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6143205 [patent_doc_number] => 20110129875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'IMMUNOSUPPRRESSIVE POLYPEPTIDES AND NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 13/011042 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 132042 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129875.pdf [firstpage_image] =>[orig_patent_app_number] => 13011042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435679 [patent_doc_number] => 08283447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Immunosuppressive polypeptides and nucleic acids' [patent_app_type] => utility [patent_app_number] => 13/011463 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 132098 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13011463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807579 [patent_doc_number] => 08445230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Immunosuppressive polypeptides and nucleic acids' [patent_app_type] => utility [patent_app_number] => 13/011351 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 132116 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13011351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958557 [patent_doc_number] => 20110182944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein' [patent_app_type] => utility [patent_app_number] => 12/930522 [patent_app_country] => US [patent_app_date] => 2011-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8650 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182944.pdf [firstpage_image] =>[orig_patent_app_number] => 12930522 [rel_patent_id] =>[rel_patent_doc_number] =>)